| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 20 |
| 1 | METHOTREXATE | 18 |
| 2 | ADALIMUMAB | 12 |
| 3 | AZATHIOPRINE | 12 |
| 4 | TEMOZOLOMIDE | 11 |
| 5 | ETANERCEPT | 10 |
| 6 | PREDNISOLONE | 10 |
| 7 | PREDNISOLONE ORAL | 10 |
| 8 | PREDNISOLONE ORAL SOLUTION | 10 |
| 9 | RITUXIMAB | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINUTUXIMAB | 1 | 0.0012 |
| 1 | TEMOZOLOMIDE | 11 | 0.0005 |
| 2 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 3 | PASIREOTIDE | 1 | 0.0004 |
| 4 | GOLD | 2 | 0.0003 |
| 5 | IRINOTECAN HYDROCHLORIDE | 3 | 0.0002 |
| 6 | ADALIMUMAB-FKJP | 9 | 0.0002 |
| 7 | ADALIMUMAB-AATY | 9 | 0.0002 |
| 8 | ADALIMUMAB-ADAZ | 9 | 0.0002 |
| 9 | AZATHIOPRINE | 12 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 21 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 18 |
| 2 | Platinum-based Drug [EPC] | 16 |
| 3 | Corticosteroid [EPC] | 15 |
| 4 | Purine Antimetabolite [EPC] | 12 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 10 |
| 7 | Topoisomerase Inhibitor [EPC] | 9 |
| 8 | Aminosalicylate [EPC] | 7 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Purine Antimetabolite [EPC] | 12 | 0.0001 |
| 2 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 21 | 0.0001 |
| 4 | Aminosalicylate [EPC] | 7 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 16 | 0.0001 |
| 6 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 18 | 0.0000 |
| 8 | Alkaloid [EPC] | 1 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |